Da Qian
Impact in
-
- Immune cells in cancer
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immunotherapy and Immune Responses
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- MicroRNA in disease regulation 3
- Cancer Genomics and Diagnostics 2
-
- RNA modifications and cancer 3
- Extracellular vesicles in disease 3
- Circular RNAs in diseases 2
- Protein Degradation and Inhibitors 2
- Co-authors
- Jinquan Cai (3 shared papers)Caijun Zha (1 shared paper)Ziwei Li (1 shared paper)Shaoshan Hu (1 shared paper)Shan Mi (1 shared paper)Lulu Li (1 shared paper)Shihong Zhao (1 shared paper)Xiangqi Meng (2 shared papers)
In The Last Decade
Da Qian
34 papers receiving 446 citations
Peers
Comparison fields: 5 of 65
- Immunology 170
- Cancer Research 70
- Genetics 34
- Oncology 60
- Molecular Biology 157
Countries citing papers authored by Da Qian
This map shows the geographic impact of Da Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da Qian more than expected).
Fields of papers citing papers by Da Qian
This network shows the impact of papers produced by Da Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da Qian. The network helps show where Da Qian may publish in the future.
Co-authors
The 25 scholars most cited alongside Da Qian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 210 | |
| 2 | 2023 | 30 | |
| 3 | 2023 | 28 | |
| 4 | 2022 | 15 | |
| 5 | 2023 | 14 | |
| 6 | 2021 | 14 | |
| 7 | 2023 | 14 | |
| 8 | 2023 | 12 | |
| 9 | 2023 | 11 | |
| 10 | 2022 | 10 | |
| 11 | 2024 | 10 | |
| 12 | 2025 | 10 | |
| 13 | 2024 | 8 | |
| 14 | 2023 | 7 | |
| 15 | 2023 | 6 | |
| 16 | 2022 | 6 | |
| 17 | 2022 | 5 | |
| 18 | 2023 | 5 | |
| 19 | 2024 | 5 | |
| 20 | 2024 | 4 |
About Da Qian
Da Qian is a scholar working on Cancer Research, Molecular Biology, Rheumatology, Immunology and Oncology, having authored 43 papers that have together received 451 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), RNA modifications and cancer (3 papers), Extracellular vesicles in disease (3 papers), MicroRNA in disease regulation (3 papers), Cancer Genomics and Diagnostics (2 papers), Circular RNAs in diseases (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Immunology (170 citations), Cancer Research (70 citations), Genetics (34 citations), Oncology (60 citations) and Molecular Biology (157 citations). Da Qian has collaborated with scholars based in China and Taiwan. Frequent co-authors include Jinquan Cai, Caijun Zha, Ziwei Li, Shaoshan Hu, Shan Mi, Lulu Li, Shihong Zhao, Xiangqi Meng, Pengfei Wu and Xuli Meng. Their work appears in journals such as Frontiers in Oncology, Cancer Cell International, Frontiers in Genetics, Journal of Oncology and Annals of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.